Phoenix Dosimetry Limited

Phoenix Dosimetry Limited

ACQUIRED: November 2023

LOCATION: Berkshire

INDUSTRY: Radiation detection


"Embarking on this new chapter with Rcapital and HTSL is an exciting new chapter for Phoenix Dosimetry. Working closely with Ben Read at HTSL, as our collaboration promises not only shared success but also the opportunity to push the boundaries of growth within our industries. Together, we look forward to shaping a future in pursuit of exceptional client service in the dosimetry industry."
- Mike Sweeney, Managing Director, Phoenix Dosimetry Limited

Phoenix Dosimetry Limited is a leader in the UK’s radiation monitoring landscape, specialising in radiological detection systems, radiotherapy dosimetry, and associated services. With a dedicated focus on Dosimetry Services and Hospitals, Phoenix is committed to providing cutting-edge radiation dosimeters, monitoring equipment, peripherals, and comprehensive service support.

Headquartered in Berkshire, Phoenix Dosimetry is led by industry veteran Mike Sweeney. As part of the transition, Mike will assume the role of Sales Director, continuing to deliver invaluable experience and leadership to the business.

Identified as a strategic bolt-on opportunity within the Rcapital portfolio for HTSL Group, which includes High Technology Sources Limited one of the UK’s leading suppliers of radioactive isotopes for over 20 years. This acquisition represents an exciting opportunity to rapidly enhance the scale of the newly combined HTSL business. The alignment and strategic fit between Phoenix and HTSL offers an exciting opportunity for mutual growth and expansion.

As part of the integration process, Rcapital, alongside skilled operators, will collaboratively work with Phoenix Dosimetry’s management team. Mike Sweeney will play a pivotal role in leading the integration efforts alongside HTSL management led by Ben Read. This approach ensures a seamless transition, leveraging the strengths of both businesses to drive sustained growth and operational excellence.

See Our
Other investments